Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ) Identifier:
First received: July 16, 2008
Last updated: August 6, 2016
Last verified: August 2014